₨ 90,000
Ventoxen (Venetoclax) 100 mg tablets are a targeted cancer therapy used to treat certain blood cancers, specifically chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and acute myeloid leukemia (AML) in specific adult patient groups. The medication is manufactured by Everest Pharmaceuticals Ltd..
Key Information
- Active Ingredient: Venetoclax, which is a selective BCL-2 inhibitor that helps restore the process of apoptosis (programmed cell death) in cancer cells.
- Medical Use: Used alone or in combination with other chemotherapy drugs for the treatment of certain types of leukemia and lymphoma.
- Dosage: Each film-coated tablet contains 100 mg of Venetoclax.
- Administration: The tablets are taken orally once daily with food and water.
- Important Precautions: Patients are at risk of tumor lysis syndrome (TLS), a potentially life-threatening condition, especially during the initial dose titration phase. Patients must drink plenty of fluids and have their blood monitored closely to manage this risk.
Common Side Effects
Common side effects include:
- Nausea and diarrhea
- Fatigue and cough
- Low blood cell counts (anemia, neutropenia, thrombocytopenia)
- Upper respiratory tract infections
Disclaimer: This information is for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional for diagnosis and treatment of a medical condition.
₨ 10,000
